The MPN Research Foundation has invested more in Interferon research in the past few years through our MPN Interferon Initiative, a global collaboration among researchers… Read More »MPNRF’S EXECUTIVE DIRECTOR DISCUSSES THE INTERFERON INITIATIVE
BLOOD ARTICLE DISCUSSES EPIGENETIC CHANGES IN MYELOFIBROSIS FOLLOWING DISCONTINUATION OF RUXOLITINIB
The MPN community is discussing the article by MPN researchers from MD Anderson – Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation – a retrospective study… Read More »BLOOD ARTICLE DISCUSSES EPIGENETIC CHANGES IN MYELOFIBROSIS FOLLOWING DISCONTINUATION OF RUXOLITINIB
Dr. Angela Fleischman has been researching the familial prevalence of MPNs for nearly ten years. A faculty member at the University of California Irvine, she… Read More »EMPOWERING THE MPN PATIENT, AND THE GOOD STEM CELLS INTO THE FUTURE
Even though MPN patients who have a rare disease many may have never heard of “Rare Disease Day” and know next to nothing about the… Read More »FEBRUARY 29TH IS RARE DISEASE DAY: 4 REASONS YOU SHOULD CARE
One question that always comes up when Bob and I talk is this: “Why don’t we have new drugs for the MPNs?” It is a… Read More »NOVEL THERAPIES: CLOSE BUT NOT CLOSE ENOUGH
December 22, 2016 MPNRF’s Executive Director Michelle Woehrle discusses research plan, their take on ASH16 and the launch of myMPN – the patient registry the… Read More »MPNRF’S EXECUTIVE DIRECTOR SPEAKS ABOUT MYMPN AND PLANS FOR THE RESEARCH
Does the smiling face of Layla Richards mark a new era in genetic medicine that could change all our lives? The story of Layla Richards… Read More »IS THIS THE BEGINNING OF GENE-EDITING MEDICINE?